Insider Transactions in Q3 2025 at Natera, Inc. (NTRA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
11,000
-5.6%
|
$1,969,000
$179.91 P/Share
|
|
Sep 19
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
25,527
-0.54%
|
$4,594,860
$180.91 P/Share
|
|
Sep 18
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
14,473
-0.61%
|
$2,605,140
$180.13 P/Share
|
|
Sep 18
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
10,000
-40.0%
|
$1,800,000
$180.0 P/Share
|
|
Sep 17
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.63%
|
$540,320
$176.25 P/Share
|
|
Sep 15
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Bona fide gift
|
Direct |
300
-0.25%
|
-
|
|
Sep 12
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
5,000
-8.48%
|
$855,000
$171.47 P/Share
|
|
Sep 02
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.81%
|
$498,000
$166.6 P/Share
|
|
Sep 02
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
5,079
-1.05%
|
$843,114
$166.47 P/Share
|
|
Aug 28
2025
|
Rowan E Chapman |
SELL
Open market or private sale
|
Direct |
2,750
-31.37%
|
$456,500
$166.99 P/Share
|
|
Aug 14
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
678
-0.22%
|
$105,090
$155.38 P/Share
|
|
Aug 14
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
875
-0.35%
|
$135,625
$155.44 P/Share
|
|
Aug 12
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,675
+1.08%
|
-
|
|
Aug 12
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
BUY
Grant, award, or other acquisition
|
Direct |
1,675
+1.33%
|
-
|
|
Aug 11
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-0.85%
|
$459,000
$153.33 P/Share
|
|
Aug 08
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.21%
|
$491,200
$160.97 P/Share
|
|
Aug 01
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.8%
|
$399,000
$133.28 P/Share
|
|
Aug 01
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
2,496
-16.46%
|
$331,968
$133.2 P/Share
|
|
Aug 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
5,807
-1.73%
|
$766,524
$132.87 P/Share
|
|
Jul 29
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,045
-1.5%
|
$417,165
$137.15 P/Share
|
|
Jul 28
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,019
-2.86%
|
$280,641
$139.81 P/Share
|
|
Jul 28
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
6,092
-3.47%
|
$846,788
$139.81 P/Share
|
|
Jul 28
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,994
-0.98%
|
$277,166
$139.81 P/Share
|
|
Jul 28
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
1,710
-1.11%
|
$237,690
$139.81 P/Share
|
|
Jul 28
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
2,206
-1.72%
|
$306,634
$139.81 P/Share
|
|
Jul 28
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
1,718
-0.07%
|
$238,802
$139.81 P/Share
|
|
Jul 28
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
479
-0.19%
|
$66,581
$139.81 P/Share
|
|
Jul 25
2025
|
Rowan E Chapman |
BUY
Grant, award, or other acquisition
|
Direct |
149
+1.67%
|
-
|
|
Jul 25
2025
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
108
+0.59%
|
-
|
|
Jul 25
2025
|
Monica Bertagnolli |
BUY
Grant, award, or other acquisition
|
Direct |
108
+2.06%
|
-
|
|
Jul 25
2025
|
Roelof Botha |
BUY
Grant, award, or other acquisition
|
Direct |
173
+2.52%
|
-
|
|
Jul 25
2025
|
Gail Boxer Marcus |
BUY
Grant, award, or other acquisition
|
Direct |
141
+1.68%
|
-
|
|
Jul 25
2025
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
153
+0.22%
|
-
|
|
Jul 25
2025
|
Brinkley Ruth Williams |
BUY
Grant, award, or other acquisition
|
Direct |
112
+2.1%
|
-
|
|
Jul 24
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
755
-0.53%
|
$104,945
$139.57 P/Share
|
|
Jul 23
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
495
-0.69%
|
$69,795
$141.28 P/Share
|
|
Jul 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.71%
|
-
|
|
Jul 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
920
-1.29%
|
$127,880
$139.58 P/Share
|
|
Jul 21
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
602
-0.84%
|
$83,678
$139.29 P/Share
|
|
Jul 21
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,622
-0.92%
|
$225,458
$139.29 P/Share
|
|
Jul 21
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
339
-0.22%
|
$47,121
$139.29 P/Share
|
|
Jul 21
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
291
-0.23%
|
$40,449
$139.29 P/Share
|
|
Jul 21
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
93
-0.04%
|
$12,927
$139.29 P/Share
|
|
Jul 21
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
464
-0.23%
|
$64,496
$139.29 P/Share
|
|
Jul 20
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+2.07%
|
-
|
|
Jul 20
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.88%
|
-
|
|
Jul 20
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
190
+0.08%
|
-
|
|
Jul 20
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.42%
|
-
|
|
Jul 16
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-1.23%
|
$457,430
$149.96 P/Share
|
|
Jul 02
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-1.35%
|
$480,000
$160.18 P/Share
|